NBIX
#714
Neurocrine Biosciences, Inc. - Common Stock
135.1 3 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.41%
Variación mensual
-14.64%
Variación en los últimos 6 meses
+6.97%
Cambio anual
-6.81%
Cierres anteriores
141.3 7
Open
139.6 0
Mínimo
134.8 9
Máximo
139.6 0
Financials
- Market Capitalization 13.74 B
- Employee 2 500
- Founded 1992
- CEO Kevin C. Gorman
- Website www.neurocrine.com
- Headquarter Delaware, United States
- FIGI BBG000GJS7C1
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
30.37
Relación precio/flujo de caja
5.08
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 451 |  TAK Takeda Pharmaceutical Company Limited American Depositary Share | 18.54 USD | -0.80% | +2.04% | -0.11% | +30.70% | 28.88 B USD | ||
| 580 |  VTRS Viatris Inc. - Common Stock | 17.25 USD | -1.65% | -1.54% | +3.48% | +66.67% | 19.81 B USD | ||
| 826 |  ELAN Elanco Animal Health Incorporated Common Stock | 22.43 USD | -0.66% | +1.22% | -4.15% | +0.16% | 11.21 B USD | ||
| 855 |  RDY Dr. Reddy's Laboratories Ltd | 12.77 USD | -0.39% | +3.32% | +7.31% | -9.24% | 10.66 B USD |